Contact Us
Drug Search Results
More Filters [+]

Methoxyflurane

Alternative Names: methoxyflurane
Latest Update: 2024-10-15
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: No Mechanism

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Inhalant

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Australia | Austria | Belgium | Bosnia | Canada | Colombia | Croatia | Czech | Denmark | Finland | France | Hong Kong | Hungary | Iceland | India | Ireland | Italy | Jordan | Latvia | Lebanon | Lithuania | Malta | Mexico | Netherlands | New Zealand | Norway | Poland | Portugal | Saudi Arabia | Singapore | Slovakia | Slovenia | South Africa | Spain | Sweden | Switzerland | Taiwan | Ukraine | United Arab Emirates | United Kingdom

Approved Indications: None

Known Adverse Events: None

Company: Mundipharma
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Methoxyflurane

Countries in Clinic: Australia, Ireland, United Kingdom

Active Clinical Trial Count: 2

Highest Development Phases

Phase 3: Acute Pain|COVID-19|Vision, Low

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
ACTRN12624001117505

P3

Not yet recruiting

Vision, Low|COVID-19

2026-09-09

MAGPIE

P3

Completed

Acute Pain

2022-06-15

Recent News Events

Date

Type

Title

05/01/2024

PubMed

 Inhaled methoxyflurane - an explorable alternative to nitrous oxide?

04/02/2024

PubMed

 Pilot study to assess the feasibility of self-administered, low-dose methoxyflurane for cystoscopic procedures.

03/07/2024

PubMed

 Skeletal fluorosis secondary to methoxyflurane use for chronic pain.

03/10/2023

News Article

 Endo Launches First Generic Version of Pylera® (bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride) Capsules

03/10/2023

News Article

 Endo Launches First Generic Version of Pylera® (bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride) Capsules

03/27/2019

News Article

 Mountain Rescue Study Launches to Investigate Use of Penthrox® (Methoxyflurane) for Trauma-related Pain in Hostile Environments

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions